IP Library Granted Patent US 7,923,109
Granted Patent B2
US 7,923,109 · App. 10/976,179 · Granted Apr 12, 2011

Inorganic nanowires

Assignees: Board of Regents, The University of Texas System; Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,923,109
App. No.
10/976,179
Granted
Apr 12, 2011
Kind
B2
Abstract

An inorganic nanowire having an organic scaffold substantially removed from the inorganic nanowire, the inorganic nanowire consisting essentially of fused inorganic nanoparticles substantially free of the organic scaffold, and methods of making same. For example, a virus-based scaffold for the synthesis of single crystal ZnS, CdS and free-standing L10 CoPt and FePt nanowires can be used, with the means of modifying substrate specificity through standard biological methods. Peptides can be selected through an evolutionary screening process that exhibit control of composition, size, and phase during nanoparticle nucleation have been expressed on the highly ordered filamentous capsid of the M13 bacteriophage. The incorporation of specific, nucleating peptides into the generic scaffold of the M13 coat structure can provide a viable template for the directed synthesis of a variety of materials including semiconducting and magnetic materials. Removal of the viral template via annealing can promote oriented aggregation-based crystal growth, forming individual crystalline nanowires. The unique ability to interchange substrate specific peptides into the linear self-assembled filamentous construct of the M13 virus introduces a material tunability not seen in previous synthetic routes. Therefore, this system provides a genetic tool kit for growing and organizing nanowires from various materials including semiconducting and magnetic materials.

Claims (23)

1. An inorganic nanowire comprising fused inorganic nanoparticles in contact with a biological scaffold, wherein the biological scaffold is a virus, a virion, or a virial subunit including capsids, or combinations thereof.

2. The inorganic nanowire according to claim 1 , wherein the inorganic nanowire has one or more crystalline domains.

3. The inorganic nanowire according to claim 1 , wherein the inorganic nanowire consists essentially of semiconductor material, metallic material, metal oxide material, magnetic material, or mixtures thereof.

4. A composition comprising a plurality of inorganic nanowires according to claim 3 , wherein the nanowires are substantially monodisperse in average length.

5. A composition comprising a plurality of inorganic nanowires according to claim 3 , wherein the nanowires are substantially monodisperse in average width.

6. A composition comprising a plurality of inorganic nanowires according to claim 3 , wherein the nanowires are substantially monodisperse in average length, and are also substantially monodisperse in average width.

7. The inorganic nanowire according to claim 1 , wherein the nanoparticles are oriented.

8. The inorganic nanowire according to claim 1 , wherein the nanoparticles comprise more than one type of nanoparticles.

9. The inorganic nanowire of claim 8 , wherein the nanoparticles are oriented in a periodic pattern.

10. The inorganic nanowire according to claim 1 , wherein the nanowire has a length of about 250 nm to about 5 microns and a width of about 5 nm to about 50 nm.

11. The inorganic nanowire according to claim 1 , wherein the inorganic nanowire is crystalline and the inorganic nanowire consists essentially of semiconductor material, metallic material, metal oxide material, magnetic material, or mixtures thereof.

12. The inorganic nanowire according to claim 1 , wherein the biological scaffold has binding sites on at least one end of the scaffold.

13. The inorganic nanowire according to claim 12 , wherein the binding site at the end of the scaffold can bind to another structure.

14. The inorganic nanowire according to claim 1 , wherein the biological scaffold is a filamentous bacteriophage.

15. A device comprising an electrode in electrical contact with a nanowire according to claim 1 .

16. A segmented nanowire comprising a plurality of connected segments of nanowires according to claim 1 .

17. A composition comprising at least 20 inorganic nanowires of claim 1 .

18. The composition of claim 17 , wherein a coefficient of variation in length of the at least 20 inorganic nanowires is less than 5%.

19. The inorganic nanowire of claim 1 , wherein the biological scaffold is a M13 bacteriophage.

20. The inorganic nanowire of claim 1 , wherein the nanowire comprises ZnS, CdS, L10, CoPt, FetPt, or combinations thereof.

21. An inorganic nanowire comprising fused inorganic nanoparticles in contact with a biological scaffold, wherein the biological scaffold is a filamentous protein.

22. An inorganic nanowire comprising fused inorganic nanoparticles in contact with a biological scaffold, wherein biological scaffold is a filamentous bacteriophage.

23. An inorganic nanowire comprising fused inorganic nanoparticles in contact with a biological scaffold, wherein biological scaffold is a M13 bacteriophage.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2009
From: BELCHER, ANGELA M.; SOLIS, DANIEL J.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 022459/0455 →
Continuity (2)
Provisional Application 60534102 · Jan 5, 2004
Related Publication 20050221083A1 · Oct 6, 2005